Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GSK in 2013. The firm invests globally and takes a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies. APVC promotes an inclusive and diverse workspace and is committed to supporting healthcare equity. Their investments focus on transformative approaches to managing diseases through bioelectronic medicine.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions